Alzheimer’s Drug Approval Sparks a Firestorm

Sadye Matula

Less than unique conditions, the U.S. Foodstuff and Drug Administration’s acceptance of the medicine aducanumab may well have been celebrated as one particular of the wonderful therapeutic improvements of 2021. The drug was proclaimed as the first medication to concentrate on the fundamental pathology of Alzheimer’s disorder. The most widespread […]